🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are delighted to share the results of our NMA, this time focused on lebrikizumab and how it compares to other systemic treatments for atopic dermatitis. Do check out our open access paper here: jamanetwork.com/journals/jamad… Check out our video here: instagram.com/reel/C9hwxF5qt…

We are delighted to present the first ‘real world’ treatment effectiveness analysis comparing dupilumab with ciclosporin and methotrexate in atopic dermatitis, which has just gone online BJD . doi.org/10.1093/bjd/lj… (To be continued in next post...)

We are grateful to all A-STAR sites and their teams and for the continued support of the British Association of Dermatologists @HealthySkin4All , in particular Shehnaz Ahmed, Zin Mon, and Simon Morrison. instagram.com/reel/C9zf3Uhqr… Interviewed by StJohns Derm Academy

We are thrilled to welcome Dr Alphonsus Yip to the team as our new Clinical Research Fellow!

We are incredibly grateful to have been awarded a commendation for Dermatology Team of the Year at the QiC Dermatology Awards hosted by Sanofi! This celebrates all the efforts from our team that runs the Paediatric Severe Eczema Clinic led by Professor Carsten Flohr.

Today is World Atopic Eczema Day, and we would like to highlight the profound impact this intensely itchy inflammatory skin disease has on patients’ lives but also make you aware of our research efforts at St John’s Institute of Dermatology! #AtopicEczemaDay

Great presentation from Prof. Mike Ardern-Jones at the #EADV today on the latest results from the A-STAR register! Congratulations to the A-STAR team led by Prof. Flohr at King’s College London and all participating sites! astar-register.org

Exciting news from the Dream-to-Treat-AD (D2TAD) registry project! We have linked 5 European TREAT registries – TREATgermany, TREAT-NL/BE, SCRATCH DK and A-STAR UK and Ireland. Find out more here:

🎉 Exciting news! We’ve just recruited the first adolescent in the UK for the COAST-2 clinical trial! This trial uses amlitelimab, an OX-40 ligand monoclonal antibody, to explore new ways to treat atopic dermatitis.

🏃‍♂️🏃‍♀️ Our Paediatric & Population-Based Dermatology Research Team is taking on the Great South Run to raise funds for the National Eczema Society and support life-changing eczema research! 💙 ajbellgreatsouthrun2024.enthuse.com/pf/popderm 🔗 Link in bio to donate!

Professor Carsten Flohr is just back from British Society for Allergy and Clinical Immunology Annual Conference, speaking on biologics in atopic dermatitis and contributing to a panel discussion on multisystem allergic disease.

🚀 Global Atopic Dermatitis Atlas (GADA) is making strides in addressing gaps in the global burden map for atopic dermatitis. Check out our latest update for ongoing and upcoming work: atopicdermatitisatlas.org/en/explore-dat… 🌍 #AtopicDermatitis #SkinHealth #EczemaAwarenessMonth #GlobalHealth #Dermatology #Eczema

Dr Helen Alexander presented at the ISAD conference, providing an overview of the TREAT trial immunology results and highlighting the key finding that MTX and CyA modulate skin and systemic immune markers with MTX showing a more sustained effect after treatment cessation.

Wrapping up an inspiring #ISADSociety conference in #Doha! 🌍 Grateful for the chance to connect, learn and share insights with experts from around the world. Here's to continued collaboration and advancements in dermatology for better patient care everywhere #AtopicDermatitis

UK-Irish Atopic Eczema Systemic Therapy Register (A-STAR) hits 1000th patient milestone! 🎉 👏 Congratulations to the Norfolk and Norwich team and their colleagues who recruited this patient. 📩 Interested in joining the A-STAR study? Contact us at: [email protected]

🌟 We're Hiring! 🌟 guysandstthomas.nhs.uk/current-vacanc…

Our 'living' update of the European guideline for the treatment of atopic eczema has just appeared: onlinelibrary.wiley.com/doi/epdf/10.11… A special 'thank you' to all members, in particular co-lead Professor Andreas Wollenberg and the EuroGuiDerm Centre team in Berlin. #eczema #treatment

We’re excited to share our latest findings from the UK TREAT Trial, now published open access in BJD: Methotrexate and ciclosporin improve skin biomarkers in paediatric atopic dermatitis 🔗 doi.org/10.1093/bjd/lj…

Revisiting our health economic analysis from the TREAT trial published in the British Journal of Dermatology! Methotrexate versus ciclosporin in the treatment of severe atopic eczema in children: an economic evaluation 🔗 doi.org/10.1093/bjd/lj…

The effects of ciclosporin and methotrexate on kidney function in the treatment of severe atopic dermatitis in children: results from the TREAT trial 🔗 doi.org/10.1093/bjd/lj…